Evaluation of Xpert ® MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
Evaluation of Xpert ® MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
复制标题
乌干达结核分枝杆菌对一线和二线药物药敏试验的 Xpert® MTB/XDR 试验评价。
DOI：
10.1101/2023.04.03.23288099
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Joloba,MosesL
中科院分区：
文献类型：
--
作者：
Katamba,Achilles;Ssengooba,Willy;Sserubiri,James;Semugenze,Derrick;William,KasuleGeorge;Abdunoor,Nyombi;Byaruhanga,Raymond;Turyahabwe,Stavia;Joloba,MosesL
耐药结核病(DR-TB)是结核病控制面临的主要挑战之一。目前迫切需要对最常用的一线和二线结核病药物进行快速、准确的药敏试验。
BackgroundDrug-Resistant Tuberculosis (DR-TB) is one of the key challenges toward TB control. There is an urgent need for rapid and accurate drug susceptibility tests (DST) for the most commonly used 1 st and 2 nd line TB drugs.